Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
about
Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@en
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@nl
type
label
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@en
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@nl
prefLabel
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@en
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@nl
P2093
P2860
P356
P1476
Elotuzumab for the Treatment o ...... f Action and SLAMF7 Signaling.
@en
P2093
Hiroto Kaneko
Junya Kuroda
Kazuho Shimura
Masafumi Taniwaki
Mihoko Yoshida
Yosuke Matsumoto
P2860
P304
P356
10.4084/MJHID.2018.014
P577
2018-02-15T00:00:00Z